旅行疫苗市场：类型（减毒疫苗、结合疫苗、DNA疫苗）、疾病（百白破、甲型肝炎、乙型肝炎）-俄乌衝突和高通胀-2023-2030年全球预测

全球旅行疫苗市场预计将在2023年大幅增长至82,670.1亿美元，复合年增长率为10.04%，2030年将达到16,181.43百万美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球旅行疫苗市场至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细资讯。

4.市场趋势：全面了解俄罗斯-乌克兰衝突和高通胀。

5.竞争评估和资讯：对主要公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.全球旅行疫苗市场规模及预测是多少？

2. 在预测期内，COVID-19 对全球旅行疫苗市场的影响有哪些障碍和影响？

3. 在预测期内，全球旅行疫苗市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球旅行疫苗市场的竞争策略是什么？

5.全球旅行疫苗市场的技术趋势和监管框架是什么？

6. 全球旅行疫苗市场主要供应商的市场份额是多少？

7. 哪些形式和策略举措被认为适合进入全球旅行疫苗市场？

目录

第 1 章前言

第 2 章研究方法

第 3 章执行摘要

第 4 章市场概述

第 5 章市场洞察

• 市场动态
  • 促进因素
    • 国际旅游日益受欢迎
    • 传染病的传播与联合疫苗的开发
    • 近期对冷链仓储基础设施的投资和改进
  • 抑制因素
    • 游客意识有限
  • 机会
    • 新疫苗技术的创新和进步
    • 政府和组织为免疫和疫苗开发提供的资金和努力
  • 课题
    • 疫苗处理和储存问题
• 市场趋势
• 新冠肺炎 (COVID-19) 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积影响
• 波特五力分析
• 价值炼和关键路径分析
• 监管框架
• 客户定制

第 6 章旅行疫苗市场：按类型

• 减毒疫苗
• 结合疫苗
• DNA疫苗
• 非活性疫苗
• 重组载体疫苗
• 亚单位疫苗
• 类毒素疫苗

第 7 章旅行疫苗市场：按疾病分类

• DPT
• 甲型肝炎
• 乙型肝炎
• 日本脑炎
• 麻疹和腮腺炎
• 脑膜炎球菌
• 狂犬病
• 伤寒
• 水痘
• 黄热病

第 8 章美洲旅行疫苗市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第 9 章亚太旅行疫苗市场

• 澳大利亚
• 中国
• 印度
• 印度尼西亚
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第 10 章欧洲、中东和非洲旅行疫苗市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第 11 章竞争态势

• FPNV定位矩阵
• 市场份额分析：主要公司
• 竞争情景分析：主要公司

第 12 章上市公司名单

第 13 章附录

• 讨论指南
• 关于许可证和价格

The Global Travel Vaccines Market is forecasted to grow significantly, with a projected USD 8,267.01 million in 2023 at a CAGR of 10.04% and expected to reach a staggering USD 16,181.43 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Travel Vaccines Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Travel Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines. The Attenuated Vaccines commanded largest market share of 23.23% in 2022, followed by Recombinant Vector Vaccines.

Based on Disease, market is studied across DPT, Hepatitis A, Hepatitis B, Japanese Encephalitis, Measles and Mumps, Meningococcal, Rabies, Typhoid, Varicella, and Yellow Fever. The Hepatitis B commanded largest market share of 11.25% in 2022, followed by Measles and Mumps.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.42% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Travel Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Travel Vaccines Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Travel Vaccines Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Travel Vaccines Market?

4. What is the competitive strategic window for opportunities in the Global Travel Vaccines Market?

5. What are the technology trends and regulatory frameworks in the Global Travel Vaccines Market?

6. What is the market share of the leading vendors in the Global Travel Vaccines Market?

7. What modes and strategic moves are considered suitable for entering the Global Travel Vaccines Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Travel Vaccines Market, by Type, 2022 vs 2030
• 4.3. Travel Vaccines Market, by Disease, 2022 vs 2030
• 4.4. Travel Vaccines Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Popularity of International Tourism
    • 5.1.1.2. Growing Prevalence of Infectious Diseases and Development of Combination Vaccines
    • 5.1.1.3. Recent Investments and Improvement in Cold Chain Storage Infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Awareness Amongst Travelers
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in Novel Vaccine Technologies and Advancements
    • 5.1.3.2. Government and Organizational Funding and Initiatives for Immunization and Vaccine Development
  • 5.1.4. Challenges
    • 5.1.4.1. Issues Related to Vaccine Handling and Storage
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Travel Vaccines Market, by Type

• 6.1. Introduction
• 6.2. Attenuated Vaccines
• 6.3. Conjugate Vaccines
• 6.4. DNA Vaccines
• 6.5. Inactive Vaccines
• 6.6. Recombinant Vector Vaccines
• 6.7. Subunit Vaccines
• 6.8. Toxoid Vaccines

7. Travel Vaccines Market, by Disease

• 7.1. Introduction
• 7.2. DPT
• 7.3. Hepatitis A
• 7.4. Hepatitis B
• 7.5. Japanese Encephalitis
• 7.6. Measles and Mumps
• 7.7. Meningococcal
• 7.8. Rabies
• 7.9. Typhoid
• 7.10. Varicella
• 7.11. Yellow Fever

8. Americas Travel Vaccines Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Travel Vaccines Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Travel Vaccines Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

1. Abbott Laboratories

2. AstraZeneca PLC

3. Bavarian Nordic A/S

4. Bharat Biotech Ltd.

5. Bio-Manguinhos

6. Bio-Med (P) Limited

7. Biological E Limited

8. Cadila Pharmaceuticals Limited

9. CSL Limited

10. Dano Vaccines & Biologicals Private Limited

11. Dynavax Technologies Corporation

12. Emergent BioSolutions Inc.

13. GlaxoSmithKline PLC

14. Incepta Pharmaceuticals Ltd.

15. Indian Immunologicals Ltd.

16. Johnson & Johnson

17. Merck & Co., Inc.

18. Novartis AG

19. Pfizer Inc.

20. Sanofi S.A.

21. Serum Institute of India Pvt. Ltd.

22. Shenzhen Kangtai Biological Products Co., Ltd.

23. Takeda Pharmaceutical Company Limited

24. Valneva SE

25. Walvax Biotechnology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. TRAVEL VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. TRAVEL VACCINES MARKET SIZE, 2022 VS 2030
• FIGURE 3. TRAVEL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
• FIGURE 6. TRAVEL VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. TRAVEL VACCINES MARKET DYNAMICS
• FIGURE 8. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. TRAVEL VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. TRAVEL VACCINES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TRAVEL VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TRAVEL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 13. TRAVEL VACCINES MARKET SIZE, BY DPT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. TRAVEL VACCINES MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. TRAVEL VACCINES MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. TRAVEL VACCINES MARKET SIZE, BY JAPANESE ENCEPHALITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. TRAVEL VACCINES MARKET SIZE, BY MEASLES AND MUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. TRAVEL VACCINES MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. TRAVEL VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. TRAVEL VACCINES MARKET SIZE, BY TYPHOID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. TRAVEL VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. TRAVEL VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 42. CHINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 44. INDIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. INDIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 46. INDONESIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. INDONESIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 48. JAPAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. JAPAN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 50. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 54. SINGAPORE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. SINGAPORE TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 56. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 58. TAIWAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. TAIWAN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. THAILAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. THAILAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 62. VIETNAM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. VIETNAM TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 64. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 67. DENMARK TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. DENMARK TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. EGYPT TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. EGYPT TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 71. FINLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. FINLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 73. FRANCE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. FRANCE TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 75. GERMANY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. GERMANY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 77. ISRAEL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. ISRAEL TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 79. ITALY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ITALY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 83. NIGERIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. NIGERIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 85. NORWAY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. NORWAY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 87. POLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. POLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 89. QATAR TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. QATAR TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 91. RUSSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. RUSSIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 93. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 97. SPAIN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SPAIN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 99. SWEDEN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SWEDEN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 101. SWITZERLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SWITZERLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. TURKEY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. TURKEY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 105. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 107. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 109. TRAVEL VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 110. TRAVEL VACCINES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 111. TRAVEL VACCINES MARKET LICENSE & PRICING